the companies have no interest in testing to see if the drugs help people with mutant genes. Since the drugs are approved they would rather give it to everyone. They get more money that way.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.